BSE filing, NSE: KRITINUT. Summary written from the filing by ALFA Finder's alert engine.
Kriti Nutrients Ltd: key numbers
- Share price
- ₹63.50
- Market cap
- ₹318.2 Cr
- Revenue (annual)
- ₹921.5 Cr
- Net profit (annual)
- ₹33.90 Cr
- P/E (TTM)
- 9.6×Sector 38.6×
- Promoter holding
- 66.68%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kriti Nutrients Ltd
All →Kriti Nutrients Results Correction
Kriti Nutrients clarified NSE's query regarding the format of the Limited Review Report attached to their financial results for the quarter ended June 30, 2026.
Kriti Nutrients Annual General Meeting
Kriti Nutrients submitted minutes of its 30th AGM held 12 Aug 2026. All five resolutions, including confirmation of Rs 3.00 interim dividend, passed.
Kriti Nutrients Management Change
Kriti Nutrients announced the reappointment of its Statutory Auditors, Chairman & Managing Director Shiv Singh Mehta, and Joint Managing Director Saurabh Singh Mehta following its 30th AGM.
Kriti Nutrients Annual General Meeting
Kriti Nutrients Limited held its 30th Annual General Meeting on August 12, 2026. The meeting covered financial statement adoption, dividend confirmation, and key auditor re-appointments.
Kriti Nutrients Q1 FY27 Results: Net Profit ₹8.9 Cr, Down 6.3% YoY
Kriti Nutrients Ltd reported revenue from operations of ₹247.1 Cr (+7.9% YoY) and net profit of ₹8.9 Cr (-6.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹8.9 Cr · -6.3% YoY
Kriti Nutrients Board Meeting Date
Kriti Nutrients Ltd has scheduled a board meeting for August 11, 2026. The meeting will consider and approve un-audited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.